Results 81 to 90 of about 2,825 (179)

Preclinical Evaluation of an Everolimus-Eluting Bioresorbable Vascular Scaffold Via a Long-Term Rabbit Iliac Artery Model. [PDF]

open access: yesTissue Eng Regen Med, 2023
Park DS   +16 more
europepmc   +1 more source

Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold

open access: yesJACC: Cardiovascular Interventions, 2015
A 48-year-old man who underwent uneventful 3.0 × 28 mm bioresorbable vascular scaffold (BVS) implantation on the mid left anterior descending coronary artery for stable angina, presented 15 months later with unstable angina.
Mangiameli A   +4 more
openaire   +2 more sources

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice. [PDF]

open access: yesJ Korean Med Sci, 2023
Lee JM   +30 more
europepmc   +1 more source

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry. [PDF]

open access: yesBMC Cardiovasc Disord, 2022
Pahmeier K   +17 more
europepmc   +1 more source

Bioresorbable Vascular Scaffolds in Women

open access: yesJACC: Cardiovascular Interventions, 2017
Gennaro, Giustino, George D, Dangas
openaire   +2 more sources

Home - About - Disclaimer - Privacy